Antibody-mediated rejection in liver transplantation: current controversies and future directions
- PMID: 24470340
- DOI: 10.1002/lt.23826
Antibody-mediated rejection in liver transplantation: current controversies and future directions
Abstract
Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.
© 2014 American Association for the Study of Liver Diseases.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical